The FDA announced that two FDA advisory committees will meet in March to discuss proposed changes to the embattled program to minimize burden on patients, pharmacies, and prescribers."
The population-based cohort study, using electronic medical record data, also evaluated the association of inflammatory bowel disease with oral tetracyclines and with acne itself.
In the commentary, dermatologists Dr Eva Rawlings Parker and Dr Markus D. Boos urge dermatologists and their medical societies to engage more meaningfully on climate change issues.